Publications by authors named "Bojena Bitman"

Claim this Profile
T
The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial.
Alison M Schram, Abdul Rafeh Naqash, Eric B Haura, Jonathan W Riess, Susanna V Ulahannan, Bojena Bitman

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer.
Tian Zhang, Michael R Harrison, Peter H O'Donnell, Ajjai S Alva, Noah M Hahn, Bojena Bitman

Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel electromechanical autoinjector, AutoTouch™, for self-injection of etanercept: real-world use and benefits.
David H Collier, Bojena Bitman, Andrew Coles, Lyrica Liu, Sandeep Kumar

Postgrad Med· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritis.
Atul Deodhar, Bojena Bitman, Yue Yang, David H Collier

Clin Rheumatol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2).
Allan Gibofsky, Grant W Cannon, David J Harrison, George J Joseph, Bojena Bitman

Clin Exp Rheumatol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy.
Kathryn Hobbs, Atul Deodhar, Brian Wang, Bojena Bitman, Joyce Nussbaum

Springerplus· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of etanercept on work and activity impairment in employed moderate to severe rheumatoid arthritis patients in the United States.
Devon Hone, Annie Cheng, Crystal Watson, Baisong Huang, Bojena Bitman

Arthritis Care Res (Hoboken)· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignancies in children and young adults on etanercept: summary of cases from clinical trials and post marketing reports.
Michele Hooper, Deborah Wenkert, Bojena Bitman, Virgil C Dias, Yessenia Bartley

Pediatr Rheumatol Online J· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting low disease activity and remission using early treatment response to antitumour necrosis factor therapy in patients with rheumatoid arthritis: exploratory analyses from the TEMPO trial.
Jeffrey R Curtis, Shuo Yang, Lang Chen, Grace S Park, Bojena Bitman

Ann Rheum Dis· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimally important difference of Health Assessment Questionnaire in psoriatic arthritis: relating thresholds of improvement in functional ability to patient-rated importance and satisfaction.
Philip J Mease, J Michael Woolley, Bojena Bitman, Brian C Wang, Denise R Globe

J Rheumatol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis